Functionally, IL-23 plays a role in the host response to pathogens as it has been observed that mucosal inflammation is dependent on IL-23 production and the development of therapies directed against IL-23 moreover substantiates the detrimental role played by this cytokine in IBD pathogenesis (Sewell and Kaser, 2022). This evidence concerns the gene IL37 and inflammatory bowel disease.